Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Methalbo 5G is a comprehensive multivitamin and herbal nutraceutical supplement developed by Daylon Healthcare. Formulated as an oral softgel capsule, it contains a diverse blend of ingredients including ginseng, green tea extract, grape seed extract, ginkgo biloba, garlic powder, guggul, ginger root extract, green coffee bean extract, glycyrrhiza glabra extract, lycopene, omega-3 fatty acids, essential amino acids, multivitamins, and multiminerals. As a consumer health product, it is marketed to support general wellness, immunity, and stamina. The supplement is indicated for conditions such as general debility, recovery from chronic illness or surgery, and recurrent infections. It functions primarily through antioxidant activity and by providing essential nutrients to support metabolic and physiological functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Methalbo 5G.